Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Smoking Cessation and Nicotine De-addiction Products Market (2017–2023)

  • NET3246090
  • 100 Pages
  • January 2019
  • Healthcare
Download Sample    Get Discount   
 
Smoking cessation and nicotine de-addiction products are devices and therapies used for treating symptoms associated with the discontinuation of nicotine consumption. According to the World Health Organization (WHO), tobacco kills around 6 Mn people each year globally, of which, almost 5 Mn deaths are because of direct tobacco use. Nicotine also causes critical ailments like cardiovascular diseases, cancer, etc. Owing to the detrimental effects of tobacco on health, governments in developed countries are encouraging smokers to refrain from consuming tobacco products. The global smoking cessation and nicotine de-addiction products market is expected to expand at a compound annual growth rate (CAGR) of 20.2%, leading to a global revenue of USD 39.51 Bn by 2023, from USD 15.77 Bn in 2018.

Products segment insights:

The global nicotine replacement therapy (NRT) market had the lowest market share (about 16%) in 2018, mainly due to the reluctance to adopt smoking cessation products, and lack of awareness about nicotine de-addiction products. On the other hand, the e-cigarettes segment is anticipated to expand at a higher CAGR of 22.0% during the forecasted period (2018-2023). This high growth can be attributed to e-cigarettes’ ability to replicate the same sensation as smoking a conventional cigarette while minimizing the health risks associated with the latter. The increasing adoption of e-cigarettes is because of the availability of a variety of flavors and nicotine concentrations.

Regional insights:

The Americas have been leading the market with its innovations in smoking cessation products, and account for approximately 42% of the global market. However, Asia-Pacific is expected to have the highest growth rate during the forecast period due to high tobacco consumption in this region, coupled with rising disposable income.

Companies covered:

1. NJOY

2. CIPLA

3. Johnson & Johnson

4. GlaxoSmithKline

5. Pfizer

6. Imperial Brands PLC

7. Nicotek, LLC.

8. Japan Tobacco Inc.

Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com, or connect with us here.

Chapter 1: Executive summary

1.1. Market scope and segmentation

1.2. Key questions answered in this study

1.3. Executive summary

Chapter 2: Global smoking cessation and nicotine de-addiction products market - overview

2.1. Global market overview – trends, market attractiveness analysis, and geography-wise market revenue (USD Bn)

2.2. Market drivers and challenges

2.3. Value chain analysis

2.4. Porter’s five forces analysis

2.5. Market size based on products (nicotine replacement therapy [NRT] and e-cigarettes)

2.5. a. NRT - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

2.5. b. E-cigarettes - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 3: The Americas smoking cessation and nicotine de-addiction products market - overview

3.1. Market overview - trends, market attractiveness analysis, revenue and growth (USD Bn)

3.2. Market drivers and challenges

3.3. Market size based on products (NRT and e-cigarettes)

3.3. a. NRT - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

3.3. b. E-cigarettes - historical (2017) and forecasted (2018-2023) market size (2018-2023) (USD Bn), and key market observations

Chapter 4: Europe smoking cessation and nicotine de-addiction products market - overview

4.1. Market overview - trends, market attractiveness analysis, revenue and growth (USD Bn)

4.2. Market drivers and challenges

4.3. Market size based on products (NRT and e-cigarettes)

4.3. a. NRT - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

4.3. b. E-cigarettes - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 5: Asia-Pacific smoking cessation and nicotine de-addiction products market - overview

5.1. Market overview - trends, market attractiveness analysis, revenue and growth (USD Bn)

5.2. Market drivers and challenges

5.3. Market size based on products (NRT and e-cigarettes)

5.3. a. NRT - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

5.3. b. E-cigarettes – historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 6: The Middle East and Africa smoking cessation and nicotine de-addiction products market - overview

6.1. Market overview - trends, market attractiveness analysis, revenue and growth (USD Bn)

6.2. Market drivers and challenges

6.3. Market size based on products (NRT and e-cigarettes)

6.3. a. NRT - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

6.3. b. E-cigarettes - historical (2017) and forecasted (2018-2023) market size (USD Bn), and key market observations

Chapter 7: Competitive landscape

7.1. Market share of key companies

7.2. Cipla*

7.2. a. Company snapshot

7.2. b. Product offerings

7.2. c. Growth strategies

7.2. d. Initiatives

7.2. e. Geographical presence

7.2. f. Key numbers

* Note: all the competitors listed below will have similar coverage

7.3. NJOY

7.4. Johnson & Johnson

7.5. GlaxoSmithKline

7.6. Pfizer

7.7. Imperial Brands PLC

7.8. Nicotek, LLC.

7.9. Japan Tobacco Inc.

Chapter 8: Conclusion

Chapter 9: Appendix

9.1. List of tables

9.2. Research methodology

9.3. Assumptions

9.4. About Netscribes Inc.

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950